Compound
← Compound
Official website →
MDLNMedline Inc.
Quotes delayed by up to 15 minutes · informational, not investment advice
Escopo e origem dos dados
- Ativo
- MDLN
- Moeda das demonstrações
- USD
- Último período anual nesta tabela
- 2025-12-31
- Fonte das demonstrações
- SEC EDGAR
Data de demonstração não é horário de cotação. Dado ausente não é zero. A cobertura varia por ativo e fonte; confira o documento original antes de interpretar um número.
Fontes e metodologiaAbout the company
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided in…
IndustryMedical - Instruments & Supplies
Smart calendar
Organizing upcoming events...
Key metrics
What the market pays
P/E
Price divided by trailing 12-month earnings
36.79×
P/B
Price divided by book value
2.34×
EV/EBITDA
Enterprise value divided by operating cash generation
14.55×
EV/Revenue
Enterprise value divided by revenue
1.25×
What the company earns
ROE
Return on shareholders’ equity
5.4%
ROA
Return on all assets
1.8%
Gross margin
What remains after product costs
25%
Operating margin
What remains after operating the business
6.1%
Net margin
How much of each revenue unit becomes profit
2.3%
What it owes
Debt / Equity
Debt for each unit of shareholders’ equity
1.09
Total debt
Sum of borrowings
$12.64B
Cash
Cash available to cover it
$2.33B
Current ratio
Short-term assets divided by short-term liabilities
4.33
Free cash flow
Cash left after investing
$604M
Risk and growth
Beta
Moves more (>1) or less (<1) than the market
-0.41
Revenue growth
Compared with the same period a year earlier
11.6%
Earnings growth
Compared with the same period a year earlier
-82%
Dividend yield
Trailing 12-month distributions divided by price
0%
Market data provider figures for the latest published period. Informational, not investment advice.
Financial statements(USD)
Income statement
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Receita | 23.23B | 25.51B | 28.43B |
| Custo dos produtos | -17.35B | -18.53B | -20.91B |
| Lucro bruto | 5.89B | 6.98B | 7.52B |
| Despesas com vendas e administrativas | -3.87B | -4.11B | -4.52B |
| Pesquisa e desenvolvimento | -60M |
News about MDLN
Yahoo Finance · 5 days ago
Medline (MDLN) Slips Amid Broader MedTech Weakness
Yahoo Finance · 11 days ago
Jim Cramer Names Medline (MDLN) a Sleeper Compounder
Follow MDLN and get agent analysis of what is moving the stock.
Open Compound